King's College London

Research portal

AADvac1, an active immunotherapy against pathological tau protein demonstrates disease-modifying effects in Alzheimer's disease: a placebo-controlled randomised phase 2 study.

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalNature Medicine
Accepted/In press1 Mar 2021

King's Authors

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454